AQ BioMed

AQ BioMedhas made new discoveries about how cells respond to chemical interactions and physical forces caused by biomedical implants. Using this knowledge, we are developing unique biocompatible materials and geometric designs that work with the body. This revolutionary approach can be applied across a wide range of technologies, including stents, shunts, artificial organs, and drug delivery devices, to make these implants more effective and longer lasting.

Our first product is the AQ™ shunt, uniquely designed to control over-pressurization inside the eye caused by glaucoma and prevent the onset of blindness.

Boulder BioMed serves as the manufacturer of the AQ shunt and Mr. Kasic serves as a fractional CEO for AQ BioMed.